The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University
Explore linked clinical trials.164 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia | B-cell Precursor Acute Lymphoblastic Leukemia (ALL) | Recruiting | Phase 1 | 2026-10-02 | NCT07854652 | |
| TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT06726577 | |
| Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-09-21 | NCT06379360 | |
| Safety and Efficacy of Ventricular Irrigation for Ventriculitis | Infections, central nervous system disorder, central nervous system infectious disorder, nervous system disorder | Recruiting | Not applicable | 2026-09-10 | NCT06358209 | |
| CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma | non-Hodgkin lymphoma | Recruiting | Phase 2 | 2026-09-09 | NCT06486337 | |
| Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-09-09 | NCT06429098 | |
| U69-CART-Cells For R/R T-ALL | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 1 | 2026-09-02 | NCT07350863 | |
| VA vs DA for Newly Diagnosed Hig-risk AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT05939180 | |
| PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not applicable | 2026-09-02 | NCT05772273 | |
| CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-02 | NCT05470777 | |
| Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2026-08-19 | NCT07774234 | |
| A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Not applicable | 2026-08-19 | NCT07762508 | |
| Safety and Feasibility of FMT for Immune Recovery After HSCT | Hematopoietic Stem Cell Transplantation; Humoral Immunodeficiency | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-12 | NCT07755319 | |
| A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis | Arterial Occlusive Diseases, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Recruiting | Not stated | 2026-08-07 | NCT07036991 | |
| VA Consolidation in Intermediate-Risk AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-08-06 | NCT07672262 | |
| Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-08-06 | NCT07670130 | |
| Venetoclax Combined With Azacitidine for Consolidation Therapy in AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-08-06 | NCT07425782 | |
| A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-07-21 | NCT05824923 | |
| A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen | Carfilzomib; Newly Diagnosed Multiple Myeloma; Sotoclax; T(11;14) | Not yet recruiting | Phase 4 | 2026-07-17 | NCT07709884 | |
| A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2026-07-13 | NCT07599423 | |
| CMV-CMI in csCMVi After HSCT | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Not stated | 2026-07-07 | NCT07688759 | |
| Study of IBR733 Cell Injection in Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-07-02 | NCT06234904 | |
| Younger vs. Older Donors in Allo-HSCT: TTE | A Target Trial Emulation Study; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; Donor Age | Not yet recruiting | Not stated | 2026-06-24 | NCT07666568 | |
| Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage | Cerebral Hemorrhage, Hypertensive, Hemorrhage, Intracerebral Hemorrhagic Stroke, Intracranial Hemorrhage, Hypertensive, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-06-24 | NCT07665827 | |
| Cousin vs. Sibling Donors in Haplo-HSCT | Hematopoietic Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Not yet recruiting | Not stated | 2026-06-23 | NCT07662382 |